510(k) K230083

SAFIRA by Medovate Limited — Product Code FRN

K230083 is an FDA 510(k) premarket notification submitted by Medovate Limited for the device "SAFIRA". The FDA issued a decision of Substantially Equivalent on October 31, 2023. The device falls under product code FRN (Pump, Infusion), a Class II device regulated under 21 CFR 880.5725.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
October 31, 2023
Date Received
January 11, 2023
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Pump, Infusion
Device Class
Class II
Regulation Number
880.5725
Review Panel
HO
Submission Type